First Approval of Regenerative Medical Products Under the PMD Act in Japan

Cell Stem Cell - United States
doi 10.1016/j.stem.2016.03.011
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Conditional Approval: Japan Lowers the Bar for Regenerative Medicine Products

Cell Stem Cell
Molecular MedicineGeneticsCell Biology
2015English

Flexible and Expedited Regulatory Review Processes for Innovative Medicines and Regenerative Medical Products in the US, the EU, and Japan

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Medical Officers of Health Under the New Act

BMJ
1872English

The Duties of Medical Officers of Health Under the Notification Act

BMJ
1892English

The Duties of Medical Officers of Health Under the Notification Act

BMJ
1892English

The Duties of Medical Officers of Health Under the Notification Act

BMJ
1892English

Elagolix: First Global Approval

Drugs
Pharmacology
2018English

The Design of Insurance Coverage for Medical Products Under Imperfect Competition

Journal of Public Economics
EconomicsEconometricsFinance
2016English

Polatuzumab Vedotin: First Global Approval

Drugs
Pharmacology
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy